SCHEMBL6136380

SCHEMBL6136380

CCOC(=O)CCNCc1ccc(OC)c(OCC)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.61
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
HDAC3 O15379 2/20 0.52
HDAC1 Q13547 2/20 0.52
HDAC2 Q92769 2/20 0.52
HDAC8 Q9BY41 2/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
HTT P42858 1/20 0.52
KDM4E B2RXH2 2/20 0.51
POLB P06746 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.49
LMNA P02545 1/20 0.48
ALDH1A1 P00352 1/20 0.48
BCHE P06276 1/20 0.47
S1PR2 O95136 1/20 0.47
S1PR1 P21453 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6136228 0.94 HDAC3 (0.58) L3MBTL1KMT2AMEN1HDAC3HDAC1
SCHEMBL6136444 0.94 LMNA (0.54) L3MBTL1KMT2AMEN1KDM4EPOLB
SCHEMBL6136381 0.84 BCHE (0.64) KMT2ACYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL9832305 0.82 ALDH1A1 (0.56) KMT2AMEN1KDM4ELMNAALDH1A1
SCHEMBL4655867 0.80 ALDH1A1 (0.57) L3MBTL1KMT2AMEN1HDAC3HDAC1
SCHEMBL16839736 0.79 LTA4H (0.60) KMT2AMEN1POLB
SCHEMBL9832496 0.79 KDM4E (0.58) L3MBTL1KMT2AMEN1HDAC3HDAC1
SCHEMBL5685284 0.78 CALM1 (0.57) KMT2AHDAC1HDAC2SMN1; SMN2LMNA
SCHEMBL3187109 0.77 KDM4E (0.64) L3MBTL1KMT2AMEN1HDAC3HDAC1
SCHEMBL9830258 0.77 MEN1 (0.61) KMT2AMEN1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042279-B1 SUBSTITUTED BETA-ALANINES AVENTIS PHARMA LTD (GB) 2005-03-02 EP disclosed
US-6352977-B1 ALANINE WITH PRODRUGS AVENTIS PHARMA LIMITED (GB) 2002-03-05 US disclosed
EP-1042279-A1 SUBSTITUTED BETA-ALANINES Aventis Pharma Limited (GB) 2000-10-11 EP disclosed
WO-1999033789-A1 SUBSTITUTED β-ALANINES AVENTIS PHARMA LIMITED (GB) 1999-07-08 WO disclosed